Apex Biotechnology (TPE:1733) Marketable Securities : NT$62 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Apex Biotechnology's Marketable Securities for the quarter that ended in Mar. 2024 was NT$62 Mil.

Apex Biotechnology's annual Marketable Securities declined from Dec. 2021 (NT$76 Mil) to Dec. 2022 (NT$66 Mil) and declined from Dec. 2022 (NT$66 Mil) to Dec. 2023 (NT$62 Mil).

Apex Biotechnology Marketable Securities Historical Data

The historical data trend for Apex Biotechnology's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Marketable Securities Chart

Apex Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

149.31

36.01

75.92

65.83

61.87

Apex Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															65.83	60.41	60.41	61.87	61.87

Apex Biotechnology Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Apex Biotechnology (TPE:1733) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Apex Biotechnology Marketable Securities Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Apex Biotechnology (TPE:1733) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078

Website

https://www.apexbio.com

Apex Biotechnology Corp engages mainly in research, development, production, manufacturing and selling of biochemical testing instruments and its detection strips, and trade of products and components relevant to the core business. The company develops and markets biosensor-based blood glucose monitoring systems. The company manufactures non-invasive diagnostic technologies, IT-based telehealth care and molecular diagnostic and traditional Chinese medicine. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, HemoSmart GOLD hemoglobin screening system among others.

Apex Biotechnology (TPE:1733) Headlines

No Headlines